Pluri Inc. Current Assets
Pluri Inc. (PLUR) had Current Assets of $8.73 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-09-10
- 2026-06-30: Assets, Current $8.73M.
- 2026-03-31: Assets, Current $10.46M.
- 2025-12-31: Assets, Current $13.80M.
- 2025-09-30: Assets, Current $16.92M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $8.73M 10-K · filed 2026-09-10 |
| 2026-03-31 | $10.46M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $13.80M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $16.92M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $22.09M 10-K · filed 2026-09-10 |
| 2025-03-31 | $27.45M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $22.37M 10-Q · filed 2025-02-11 |
| 2024-09-30 | $27.03M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $31.11M 10-K · filed 2025-09-17 |
| 2024-03-31 | $27.37M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $32.25M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $35.26M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $41.41M 10-K · filed 2024-09-18 |
| 2023-03-31 | $46.69M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $50.14M 10-Q · filed 2023-02-13 |
| 2022-09-30 | $49.72M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $57.75M 10-K · filed 2023-09-12 |
| 2022-03-31 | $64.31M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $60.15M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $62.83M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $67.37M 10-K · filed 2022-09-21 |
| 2021-03-31 | $49.82M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $45.25M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $42.69M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $48.46M 10-K · filed 2021-09-13 |
| 2020-03-31 | $17.82M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $19.23M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $21.47M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $26.37M 10-K · filed 2020-09-10 |
| 2019-03-31 | $13.20M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $18.35M 10-Q · filed 2019-02-06 |
| 2018-09-30 | $24.45M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $32.04M 10-K · filed 2019-09-12 |
| 2018-03-31 | $35.71M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $37.07M 10-Q · filed 2018-02-06 |
| 2017-09-30 | $22.84M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $29.02M 10-K · filed 2018-09-12 |
| 2017-03-31 | $34.60M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $22.95M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $30.31M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $35.60M 10-K · filed 2017-09-07 |
| 2016-03-31 | $39.13M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $44.78M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $48.81M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $56.87M 10-K · filed 2016-09-07 |
| 2015-03-31 | $43.69M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $47.13M 10-Q · filed 2015-02-05 |
| 2014-09-30 | $52.29M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $61.99M 10-K · filed 2015-09-09 |
| 2014-03-31 | $64.71M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $58.40M 10-Q · filed 2014-02-05 |
| 2013-09-30 | $52.47M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $55.09M 10-K · filed 2014-09-11 |
| 2013-03-31 | $61.11M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $66.27K 10-Q · filed 2013-01-31 |
| 2012-09-30 | $69.98M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $38.19M 10-K · filed 2013-09-11 |
| 2012-03-31 | $41.45M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $43.84M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $46.36M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $43.30M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |